Alzheimer's Disease Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- People who speak Mandarin.
- People who have not been diagnosed with dementia.
- People whose scores on two memory and thinking tests (called the MMSE and CDR) meet the specific levels required by the trial.
- People who have low levels of certain proteins in their blood that are linked to brain cell activity (specifically, all four of the following must be below set levels: GAP43, synaptotagmin 1, neurogranin, and SNAP25).
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People who have been diagnosed with a major brain or nervous system condition — such as Alzheimer's disease, Parkinson's disease, stroke, brain inflammation, or epilepsy — or any other condition that could affect thinking or interfere with test results.
- People who have a history of psychotic episodes, or who have significant depression (as measured by a score above 24 on a standard depression rating scale).
- People who have serious health conditions such as cancer, heart or blood vessel disease, or bone and joint disorders that could affect their ability to take part in the trial's tasks.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Longfei Jia, MD,PhD, Xuanwu Hospital, Beijing
Phone: +86 10 83199456
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change in cognitive function over time as assessed by the Montreal Cognitive Assessment (MoCA); Change in cognitive function over time as assessed by Mini Mental State Examination (MMSE); Change in cognitive function over time as assessed by Clinical Dementia Rating (CDR); Change in cognitive function over time as assessed by Verbal Fluency Test; Change in cognitive function over time as assessed by Digit Span Test-Forward and Backward; Change in cognitive function over time as assessed by Trail-Making Test Parts A and B (TMT-A and TMT-B); Change in cognitive function over time as assessed by...
Can't join this trial?
Data last synced from ClinicalTrials.gov: 18 August 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.